T1	Intervention 334 409	randomly assigned to risperidone (0.5 to 3.5 mg/day) or placebo for 8 weeks
T2	Intervention 612 784	Dependent measures included tests of sustained attention, verbal learning, hand-eye coordination, and spatial memory assessed before, during, and after the 8-week treatment
